Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2000 | 1 |
2011 | 1 |
2013 | 1 |
2020 | 1 |
2024 | 0 |
PubMed Citations for id: 6603792
4 results
Results by year
Filters applied: . Clear all
Page 1
High-Content Screening of Eukaryotic Kinase Inhibitors Identify CHK2 Inhibitor Activity Against Mycobacterium tuberculosis.
Front Microbiol. 2020 Sep 18;11:553962. doi: 10.3389/fmicb.2020.553962. eCollection 2020.
Front Microbiol. 2020.
PMID: 33042061
Free PMC article.
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Gao Y, Davies SP, Augustin M, Woodward A, Patel UA, Kovelman R, Harvey KJ.
Gao Y, et al.
Biochem J. 2013 Apr 15;451(2):313-28. doi: 10.1042/BJ20121418.
Biochem J. 2013.
PMID: 23398362
Item in Clipboard
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR.
Anastassiadis T, et al.
Nat Biotechnol. 2011 Oct 30;29(11):1039-45. doi: 10.1038/nbt.2017.
Nat Biotechnol. 2011.
PMID: 22037377
Free PMC article.
Item in Clipboard
Pyrrolo[2,3-d]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck II.
Burchat AF, Calderwood DJ, Hirst GC, Holman NJ, Johnston DN, Munschauer R, Rafferty P, Tometzki GB.
Burchat AF, et al.
Bioorg Med Chem Lett. 2000 Oct 2;10(19):2171-4. doi: 10.1016/s0960-894x(00)00442-x.
Bioorg Med Chem Lett. 2000.
PMID: 11012022
Item in Clipboard
Cite
Cite